Evidence map›Paper›PMID 34287058›Full record

ArticleMicrobiology spectrum2021

Durable Antibody Responses in Staff at Two Long-Term Care Facilities, during and Post SARS-CoV-2 Outbreaks.

Emily N Gallichotte, Mary Nehring, Michael C Young, Sierra Pugh, Nicole R Sexton, Emily Fitzmeyer, Kendra M Quicke, Megan Richardson, Kristy L Pabilonia, Nicole Ehrhart and 3 more

Open access · goldAbstract read
In one paragraph

Article in Microbiology spectrum, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.6field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. SARS-CoV-2 outbreak in lions, tigers and hyenas at Denver Zoo.bioRxiv : the preprint server for biology · 2024
    Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 1 institution in 1 country.

Emily N GallichotteDepartment of Microbiology, Immunology and Pathology, Colorado State Universitygrid.47894.36, Fort Collins, Colorado, USA.ORCID 0000-0002-8937-5583
Mary NehringDepartment of Microbiology, Immunology and Pathology, Colorado State Universitygrid.47894.36, Fort Collins, Colorado, USA.
Michael C YoungDepartment of Microbiology, Immunology and Pathology, Colorado State Universitygrid.47894.36, Fort Collins, Colorado, USA.
Sierra PughDepartment of Statistics, Colorado State Universitygrid.47894.36, Fort Collins, Colorado, USA.
Nicole R SextonDepartment of Microbiology, Immunology and Pathology, Colorado State Universitygrid.47894.36, Fort Collins, Colorado, USA.ORCID 0000-0002-5621-7618
Emily FitzmeyerDepartment of Microbiology, Immunology and Pathology, Colorado State Universitygrid.47894.36, Fort Collins, Colorado, USA.
Kendra M QuickeDepartment of Microbiology, Immunology and Pathology, Colorado State Universitygrid.47894.36, Fort Collins, Colorado, USA.
Megan RichardsonDepartment of Microbiology, Immunology and Pathology, Colorado State Universitygrid.47894.36, Fort Collins, Colorado, USA.
Kristy L PabiloniaDepartment of Microbiology, Immunology and Pathology, Colorado State Universitygrid.47894.36, Fort Collins, Colorado, USA.
Nicole EhrhartColumbine Health Systems Center for Healthy Aging and Department of Clinical Sciences, Colorado State Universitygrid.47894.36, Fort Collins, Colorado, USA.
Bailey K FosdickDepartment of Statistics, Colorado State Universitygrid.47894.36, Fort Collins, Colorado, USA.
Sue VandeWoudeDepartment of Microbiology, Immunology and Pathology, Colorado State Universitygrid.47894.36, Fort Collins, Colorado, USA.ORCID 0000-0001-9227-1622
Gregory D EbelDepartment of Microbiology, Immunology and Pathology, Colorado State Universitygrid.47894.36, Fort Collins, Colorado, USA.ORCID 0000-0002-4458-9959
Colorado State University · US

Funding

Flavivirus cellular tropisms driving dissemination and transmission in mosquito vectorsF32AI150123 · NIAID · COLORADO STATE UNIVERSITY · PI QUICKE, KENDRA MARIE · 2020 to 2022
$204k
Boettcher Foundation (The Boettcher Foundation)Colorado State University (CSU)NIAID NIH HHS F32 AI150123
6 · The paper itself

Abstract

SARS-CoV-2 has had a disproportionate impact on nonhospital health care settings, such as long-term-care facilities (LTCFs). The communal nature of these facilities, paired with the high-risk profile of residents, has resulted in thousands of infections and deaths and a high case fatality rate. To detect presymptomatic infections and identify infected workers, we performed weekly surveillance testing of staff at two LTCFs, which revealed a large outbreak at one of the sites. We collected serum from staff members throughout the study and evaluated it for binding and neutralization to measure seroprevalence, seroconversion, and type and functionality of antibodies. At the site with very few incident infections, we detected that over 40% of the staff had preexisting SARS-CoV-2 neutralizing antibodies, suggesting prior exposure. At the outbreak site, we saw rapid seroconversion following infection. Neutralizing antibody levels were stable for many weeks following infection, suggesting a durable, long-lived response. Receptor-binding domain antibodies and neutralizing antibodies were strongly correlated. The site with high seroprevalence among staff had two unique introductions of SARS-CoV-2 into the facility through seronegative infected staff during the period of study, but these did not result in workplace spread or outbreaks. Together, our results suggest that a high seroprevalence rate among staff can contribute to immunity within a workplace and protect against subsequent infection and spread within a facility.

Indexed as

Antibody FormationDisease OutbreaksLong-Term CareAntibodies, NeutralizingAntibodies, ViralAsymptomatic InfectionsBinding Sites, AntibodyCOVID-19COVID-19 TestingHumansImmunologic SurveillanceRNA, ViralSARS-CoV-2Sensitivity and SpecificitySeroepidemiologic StudiesSpike Glycoprotein, CoronavirusAntibodies, NeutralizingAntibodies, ViralRNA, ViralSpike Glycoprotein, Coronavirusspike protein, SARS-CoV-2adaptive immunitycoronavirusneutralizing antibodiessurveillance studies

Identifiers

PMID34287058
PMCPMC8552744
OpenAlexW3184944956

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.